Diabetes Mellitus  >>  autologous hematopoietic stem cell therapy  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
autologous hematopoietic stem cell therapy / Northwestern University
NCT00315133: Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus

Completed
1/2
25
RoW
Immunosuppression and autologous stem cell transplantation
University of Sao Paulo, Northwestern University, Genzyme, a Sanofi Company
Type 1 Diabetes Mellitus
12/10
12/14

Download Options